TY  - GEN
AU  - Gómez-Pérez, R
AU  - Redondo, M
AU  - Martínez, A
AU  - Gil, C
AU  - Gonzalez, Carlos
AU  - Bravo, Beatriz
AU  - Ballester, Alicia
AU  - Eguiluz, Cesar
AU  - Ballester, Sara
PY  - 2013
DO  - 10.1111/bph.12308
SN  - 0007-1188
UR  - http://hdl.handle.net/20.500.12105/10630
AB  - Background and purpose: PDE4 inhibition suppresses experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). However, side effects hinder PDE4 inhibitors clinical use. PDE7 inhibition might constitute an alternative...
LA  - eng
PB  - Wiley
KW  - Animals
KW  - Anti-Inflammatory Agents
KW  - Brain
KW  - Cells, Cultured
KW  - Cyclic Nucleotide Phosphodiesterases, Type 4
KW  - Cyclic Nucleotide Phosphodiesterases, Type 7
KW  - Encephalomyelitis, Autoimmune, Experimental
KW  - Forkhead Transcription Factors
KW  - Inflammation Mediators
KW  - Interleukin-10
KW  - Interleukin-17
KW  - Interleukins
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Phosphodiesterase 4 Inhibitors
KW  - Rolipram
KW  - Spleen
KW  - T-Lymphocytes, Regulatory
TI  - Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis
TY  - research article
ER  -